Eli Lilly and Co (MIC:LLY-RM) Inventories, Raw Materials & Components: ₽305,890.51 Mil (As of Mar. 2026)


What is Eli Lilly and Co Inventories, Raw Materials & Components?

Eli Lilly and Co MIC:LLY-RM 98 Inventories, Raw Materials & Components is ₽305,890.51 Mil as of Mar. 2026. GuruFocus rates MIC:LLY-RM with a GF Score™ of 98/100. The stock has 6 warning signs investors should review.

Eli Lilly and Co's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ₽305,890.51 Mil.

Eli Lilly and Co's quarterly raw materials increased from Sep. 2025 (₽282,195.26 Mil) to Dec. 2025 (₽285,152.87 Mil) and increased from Dec. 2025 (₽285,152.87 Mil) to Mar. 2026 (₽305,890.51 Mil).

Eli Lilly and Co's annual raw materials increased from Dec. 2023 (₽147,083.93 Mil) to Dec. 2024 (₽250,279.92 Mil) and increased from Dec. 2024 (₽250,279.92 Mil) to Dec. 2025 (₽285,152.87 Mil).

Eli Lilly and Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co Inventories, Raw Materials & Components Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53,026.18 49,076.28 147,083.93 250,279.92 285,152.87

Eli Lilly and Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 222,015.77 244,950.78 282,195.26 285,152.87 305,890.51

Eli Lilly and Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₽305,890.51 Mil mean?
Eli Lilly and Co (MIC:LLY-RM) has a Inventories, Raw Materials & Components of ₽305,890.51 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Eli Lilly and Co and its competitors.
Is Eli Lilly and Co's Inventories, Raw Materials & Components too high?
Eli Lilly and Co's current Inventories, Raw Materials & Components is ₽305,890.51 Mil. Overall, Eli Lilly and Co has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.
How does Eli Lilly and Co's Inventories, Raw Materials & Components compare to JNJ and ABBV?
Eli Lilly and Co's Inventories, Raw Materials & Components of ₽305,890.51 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Eli Lilly and Co and its competitors. Eli Lilly and Co's current Inventories, Raw Materials & Components is ₽305,890.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eli Lilly and Co stock overvalued right now?
Eli Lilly and Co (MIC:LLY-RM) has a current Inventories, Raw Materials & Components of ₽305,890.51 Mil. The current Inventories, Raw Materials & Components is ₽305,890.51 Mil. Eli Lilly and Co's overall GF Score™ is 98/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Eli Lilly and Co (MIC:LLY-RM), the current Inventories, Raw Materials & Components is ₽305,890.51 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.